Estados financieros detallados de ImageneBio Inc (IMA): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
ImageneBio Inc registró ingresos de $800000 en el último ejercicio fiscal, con un CAGR de 5 años del -38.6%.
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $4.93, IMA presenta beneficios negativos (P/E no significativo) y un ROE del -38.99%. La capitalización bursátil es de $56M.
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Ingresos | $990000 | $13.8M | $9.2M | $31.0M | $15.6M | $9.2M | $3.5M | $800000 |
| Coste de Ventas | $39.0M | $24.9M | $44.8M | $47.1M | $64.3M | $1.0M | $1.5M | $1.0M |
| Beneficio Bruto | -$38.0M | -$11.2M | -$35.7M | -$16.1M | -$48.7M | $8.1M | $2.0M | -$233000 |
| I+D | $38.6M | $24.9M | $44.8M | $47.1M | $64.3M | $59.7M | $32.1M | $28.5M |
| Generales y Administrativos | $2.9M | $7.3M | $8.9M | $18.0M | $22.2M | $24.9M | $8.4M | $20.7M |
| Gastos Operativos | $41.5M | $7.3M | $8.9M | $18.0M | $22.2M | $83.6M | $39.0M | $48.2M |
| Beneficio Operativo | -$40.9M | -$18.5M | -$44.5M | -$34.1M | -$70.9M | -$75.4M | -$37.0M | -$48.5M |
| EBITDA | -$40.4M | -$18.2M | -$44.2M | -$33.6M | -$68.0M | -$67.3M | -$35.0M | -$44.7M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$40.9M | -$16.8M | -$44.3M | -$34.1M | -$68.8M | -$68.3M | -$36.6M | -$45.7M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | -$162000 | $13000 | -$350000 |
| Beneficio Neto | -$40.9M | -$16.8M | -$44.3M | -$34.1M | -$68.8M | -$68.2M | -$36.6M | -$45.3M |
| BPA | $-13.68 | $-5.63 | $-14.81 | $-11.38 | $-22.80 | $-19.60 | $-40.52 | $-9.64 |
| BPA Diluido | $-13.68 | $-5.63 | $-14.81 | $-11.38 | $-22.80 | $-19.60 | $-40.52 | $-9.64 |
| Acciones en Circulación (Diluidas) | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | $3.5M | $1.2M | $5.4M |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $18.2M | $82.1M | $162.5M | $232.2M | $59.9M | $119.9M | $39.4M | $35.0M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | $97.0M | $55.6M | $85.0M | $40.8M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.3M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $20.0M | $85.2M | $166.0M | $236.5M | $160.0M | $178.7M | $127.2M | $140.3M |
| Inmovilizado Material | $696000 | $769000 | $1.6M | $9.0M | $8.5M | $8.0M | $4.2M | $790000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $20.7M | $86.0M | $168.4M | $247.9M | $172.3M | $192.1M | $141.5M | $153.0M |
| Cuentas por Pagar | $2.3M | $935000 | $2.1M | $2.4M | $2.1M | $2.1M | $897000 | $1.4M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $3.8M | $24.3M | $28.3M | $27.2M | $21.5M | $14.2M | $10.8M | $11.2M |
| Deuda a Largo | $62.6M | 0 | 0 | 0 | 0 | 0 | 0 | $7.0M |
| Pasivos Totales | $66.5M | $147.4M | $269.5M | $40.0M | $25.3M | $22.3M | $15.6M | $19.8M |
| Reservas | -$50.3M | -$67.1M | -$111.3M | -$145.5M | -$214.2M | -$282.4M | -$331.6M | -$230.1M |
| Patrimonio Neto | -$45.8M | -$61.5M | -$101.0M | $207.9M | $147.0M | $169.8M | $125.9M | $133.1M |
| Deuda Total | $62.6M | 0 | $186000 | $7.0M | $5.7M | $10.7M | $7.5M | $10.0M |
| Deuda Neta | $44.4M | -$82.1M | -$162.3M | -$225.2M | -$151.3M | -$164.7M | -$116.9M | -$65.8M |
| Capital Circulante | $16.2M | $60.9M | $137.6M | $209.3M | $138.5M | $164.5M | $116.4M | $129.1M |
Flujo de Caja (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$40.9M | -$16.8M | -$44.3M | -$34.1M | -$68.8M | -$68.2M | -$49.2M | -$52.4M |
| Amortizaciones | $422000 | $243000 | $300000 | $544000 | $751000 | $1.0M | $490000 | $328000 |
| Compensación en Acciones | $314000 | $1.2M | $1.8M | $5.2M | $7.5M | 0 | $5.3M | $15.4M |
| Cambio en Capital Circulante | $58000 | $63.5M | -$7.8M | -$33.0M | -$15.1M | -$21.7M | -$4.0M | -$19.2M |
| Flujo de Caja Operativo | -$11.6M | $47.9M | -$37.8M | -$60.3M | -$74.1M | -$79.7M | -$46.0M | -$47.8M |
| Inversiones (CapEx) | -$305000 | -$316000 | -$766000 | -$1.8M | -$1.4M | -$414000 | 0 | 0 |
| Adquisiciones | $11.3M | 0 | $3.7M | 0 | 0 | 0 | 0 | -$5.2M |
| Recompra de Acciones | 0 | 0 | -$57000 | 0 | 0 | -$663000 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$11.9M | $47.6M | -$38.6M | -$62.0M | -$75.5M | -$80.2M | -$46.0M | -$47.8M |
Crecimiento y Márgenes (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +1289.2% | -33.1% | +237.0% | -49.6% | -41.3% | -61.8% | -77.1% | |
| Crecimiento Beneficio Neto (anual) | +58.8% | -163.2% | +22.9% | -101.6% | +0.9% | +46.4% | -24.0% | |
| Crecimiento BPA (anual) | +58.8% | -163.1% | +23.2% | -100.4% | +14.0% | -106.7% | +76.2% | |
| Cambio en Acciones (anual) | +0.0% | +0.0% | +0.3% | +0.6% | +15.3% | -65.7% | +354.9% | |
| Crecimiento FCF (anual) | +499.7% | -181.1% | -60.7% | -21.8% | -6.1% | +42.6% | -4.0% | |
| Margen Bruto | -3838.0% | -81.3% | -387.8% | -52.0% | -311.8% | 88.9% | 56.4% | -29.1% |
| Margen Operativo | -4130.7% | -134.5% | -484.2% | -110.2% | -454.0% | -823.3% | -1057.1% | -6056.4% |
| Margen EBITDA | -4085.2% | -132.7% | -481.0% | -108.3% | -435.5% | -734.8% | -1000.8% | -5583.2% |
| Margen Neto | -4127.8% | -122.3% | -481.4% | -110.1% | -440.3% | -744.2% | -1044.8% | -5668.6% |
| Margen FCF | -1203.3% | 346.2% | -419.8% | -200.1% | -483.7% | -875.1% | -1314.4% | -5980.5% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | 0.2% | -0.0% | 0.8% |
Datos por Acción (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-3.99 | $15.94 | $-12.92 | $-20.69 | $-25.05 | $-23.05 | $-38.52 | $-8.81 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | $3.5M | $1.2M | $5.4M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -38.99% |
| Rentabilidad sobre capital invertido | -39.76% |
| Rentabilidad sobre activos | -34.52% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 21.47 |
Ratios Clave (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| P/E | -28.07 | -68.21 | -25.93 | -13.22 | -1.40 | -1.21 | -0.49 | -0.72 |
| P/VC | -25.03 | -18.67 | -11.35 | 2.17 | 0.65 | 0.48 | 0.19 | 0.28 |
| P/V | 1158.83 | 83.42 | 124.78 | 14.56 | 6.16 | 8.98 | 6.71 | 46.85 |
| Margen Bruto | -3838.0% | -81.3% | -387.8% | -52.0% | -311.8% | 88.9% | 56.4% | -29.1% |
| Margen Operativo | -4130.7% | -134.5% | -484.2% | -110.2% | -454.0% | -823.3% | -1057.1% | -6056.4% |
| Margen Neto | -4127.8% | -122.3% | -481.4% | -110.1% | -440.3% | -744.2% | -1044.8% | -5668.6% |
Empresas relacionadas: ARTV · CNTB · CNTX · IFRX · KLRS · MGX · OVID
Explorar sector: Healthcare · Biotechnology
Más secciones de IMA: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones